We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants

Delisted

TCBPW was delisted on the 21st of March, 2025.

6 hedge funds and large institutions have $14.1K invested in TC BioPharm (Holdings) plc Warrants in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 86 (-2)

44% less capital invested

Capital invested by funds: $25.1K → $14.1K (-$11K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
KC
1
Kepos Capital
New York
$9K
NCM
2
Nantahala Capital Management
Connecticut
$4.71K
ACM
3
Altium Capital Management
New York
$376
UBS Group
4
UBS Group
Switzerland
$22 -$229 -12,515 -92%
Bank of America
5
Bank of America
North Carolina
$12 +$1 +53 +10%
AC
6
Armistice Capital
New York
-$61 -1,882,352 Closed
VF
7
Virtu Financial
New York
-$294 -16,064 -54%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
-$297 -11,406 Closed

TCBPW Hedge Fund Activity: Q1 2024 in Review

6 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q1 2024, worth a combined $14.1K — down 44% from $25.1K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TCBPW and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Bank of America, adding an estimated $1. The largest seller was Susquehanna International Group, exiting entirely with an estimated $297 sold.

  • 6 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q1 2024, down from 8 in Q4 2023.
  • Funds reported $14.1K of TC BioPharm (Holdings) plc Warrants stock for Q1 2024, down 44% quarter-over-quarter.
  • 0 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q1 2024 and 2 closed out, a net change of -2 holders.
  • The largest TC BioPharm (Holdings) plc Warrants buyer in Q1 2024 was Bank of America, an estimated $1 added.
  • The largest TC BioPharm (Holdings) plc Warrants seller in Q1 2024 was Susquehanna International Group, an estimated $297 sold.

Based on aggregated 13F filings for Q1 2024.